A detailed history of Parkwoods Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Parkwoods Wealth Partners, LLC holds 591 shares of LLY stock, worth $469,336. This represents 0.43% of its overall portfolio holdings.

Number of Shares
591
Holding current value
$469,336
% of portfolio
0.43%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $456,334 - $567,371
591 New
591 $524 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Parkwoods Wealth Partners, LLC Portfolio

Follow Parkwoods Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwoods Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwoods Wealth Partners, LLC with notifications on news.